Literature DB >> 26396237

LRRK2 autophosphorylation enhances its GTPase activity.

Zhiyong Liu1, James A Mobley1, Lawrence J DeLucas1, Richard A Kahn1, Andrew B West2.   

Abstract

The leucine-rich repeat kinase (LRRK)-2 protein contains nonoverlapping GTPase and kinase domains, and mutation in either domain can cause Parkinson disease. GTPase proteins are critical upstream modulators of many effector protein kinases. In LRRK2, this paradigm may be reversed, as the kinase domain phosphorylates its own GTPase domain. In this study, we found that the ameba LRRK2 ortholog ROCO4 phosphorylates the GTPase domain [termed Ras-of-complex (ROC) domain in this family] of human LRRK2 on the same residues as the human LRRK2 kinase. Phosphorylation of ROC enhances its rate of GTP hydrolysis [from kcat (catalytic constant) 0.007 to 0.016 min(-1)], without affecting GTP or GDP dissociation kinetics [koff = 0.093 and 0.148 min(-1) for GTP and GDP, respectively). Phosphorylation also promotes the formation of ROC dimers, although GTPase activity appears to be equivalent between purified dimers and monomers. Modeling experiments show that phosphorylation induces conformational changes at the critical p-loop structure. Finally, ROC appears to be one of many GTPases phosphorylated in p-loop residues, as revealed by alignment of LRRK2 autophosphorylation sites with GTPases annotated in the phosphoproteome database. These results provide an example of a novel mechanism for kinase-mediated control of GTPase activity. © FASEB.

Entities:  

Keywords:  G-protein; GTP-hydrolysis; Parkinson disease; ROC; phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 26396237      PMCID: PMC4684519          DOI: 10.1096/fj.15-277095

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  GAPs: Terminator versus effector functions and the role(s) of ArfGAP1 in vesicle biogenesis.

Authors:  Richard A Kahn
Journal:  Cell Logist       Date:  2011-03

2.  Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.

Authors:  Junpeng Deng; Patrick A Lewis; Elisa Greggio; Eli Sluch; Alexandra Beilina; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

3.  Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation.

Authors:  Shogo Kamikawaji; Genta Ito; Tomoko Sano; Takeshi Iwatsubo
Journal:  Biochemistry       Date:  2013-08-23       Impact factor: 3.162

4.  The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

Authors:  Patrick A Lewis; Elisa Greggio; Alexandra Beilina; Shushant Jain; Acacia Baker; Mark R Cookson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-10       Impact factor: 3.575

5.  The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.

Authors:  Elisa Greggio; Ibardo Zambrano; Alice Kaganovich; Alexandra Beilina; Jean-Marc Taymans; Veronique Daniëls; Patrick Lewis; Shushant Jain; Jinhui Ding; Ali Syed; Kelly J Thomas; Veerle Baekelandt; Mark R Cookson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

6.  The structural basis for the transition from Ras-GTP to Ras-GDP.

Authors:  Brian E Hall; Dafna Bar-Sagi; Nicolas Nassar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

7.  The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.

Authors:  Soumya Ray; Samantha Bender; Stephanie Kang; Regina Lin; Marcie A Glicksman; Min Liu
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

8.  Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.

Authors:  Christian Johannes Gloeckner; Karsten Boldt; Felix von Zweydorf; Sandra Helm; Ludwig Wiesent; Hakan Sarioglu; Marius Ueffing
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

9.  Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.

Authors:  Laura Civiero; Renée Vancraenenbroeck; Elisa Belluzzi; Alexandra Beilina; Evy Lobbestael; Lauran Reyniers; Fangye Gao; Ivan Micetic; Marc De Maeyer; Luigi Bubacco; Veerle Baekelandt; Mark R Cookson; Elisa Greggio; Jean-Marc Taymans
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

10.  Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.

Authors:  Alexandria Beilina; Iakov N Rudenko; Alice Kaganovich; Laura Civiero; Hien Chau; Suneil K Kalia; Lorraine V Kalia; Evy Lobbestael; Ruth Chia; Kelechi Ndukwe; Jinhui Ding; Mike A Nalls; Maciej Olszewski; David N Hauser; Ravindran Kumaran; Andres M Lozano; Veerle Baekelandt; Lois E Greene; Jean-Marc Taymans; Elisa Greggio; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-07       Impact factor: 11.205

View more
  25 in total

1.  The Role of Human LRRK2 in Methylmercury-Induced Inhibition of Microvesicle Formation of Cephalic Neurons in Caenorhabditis elegans.

Authors:  Tao Ke; Abel Santamaria; Joao B T Rocha; Alexey A Tinkov; Rongzhu Lu; Aaron B Bowman; Michael Aschner
Journal:  Neurotox Res       Date:  2020-07-29       Impact factor: 3.911

2.  LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network.

Authors:  Zhiyong Liu; Nicole Bryant; Ravindran Kumaran; Alexandra Beilina; Asa Abeliovich; Mark R Cookson; Andrew B West
Journal:  Hum Mol Genet       Date:  2018-01-15       Impact factor: 6.150

3.  Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics.

Authors:  Chun-Xiang Wu; Jingling Liao; Yangshin Park; Xylena Reed; Victoria A Engel; Neo C Hoang; Yuichiro Takagi; Steven M Johnson; Mu Wang; Mark Federici; R Jeremy Nichols; Ruslan Sanishvili; Mark R Cookson; Quyen Q Hoang
Journal:  J Biol Chem       Date:  2019-02-22       Impact factor: 5.157

4.  The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitro.

Authors:  Zhiyong Liu; Andrew B West
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2016-12-08       Impact factor: 3.036

Review 5.  Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.

Authors:  An Phu Tran Nguyen; Darren J Moore
Journal:  Adv Neurobiol       Date:  2017

Review 6.  Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.

Authors:  Md Shariful Islam; Darren J Moore
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

7.  Identification of bona-fide LRRK2 kinase substrates.

Authors:  Andrew B West; Mark R Cookson
Journal:  Mov Disord       Date:  2016-04-29       Impact factor: 10.338

Review 8.  The pseudoGTPase group of pseudoenzymes.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  FEBS J       Date:  2020-09-17       Impact factor: 5.542

Review 9.  Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease.

Authors:  Andrew B West
Journal:  Exp Neurol       Date:  2017-07-29       Impact factor: 5.330

10.  The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2.

Authors:  Xiaorong Huang; Chunxiang Wu; Yangshin Park; Xuwei Long; Quyen Q Hoang; Jingling Liao
Journal:  FASEB J       Date:  2018-12-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.